We’re not just here to improve care—we’re here to honor it. pRxcision was built on a conviction: that the first dose is sacred. And every patient deserves one guided by clarity, speed, and moral courage. These are the stewards behind that mission.
Chris is a scientist of precision and a leader of foresight. With 25 years of experience as a pharmacometrician, he’s helped shape drug development across adult, pediatric, and infectious disease populations.
He’s led BARDA-backed efforts to develop scalable countermeasures for national health threats and guided regulatory strategies that move products from data to market with credibility and speed.
His clarity is instinctual. His grasp of complexity, second nature. At Prxcision, Chris doesn’t just guide the science—he sees what’s coming before most know where to look.
Dr. Paul G. Ambrose
Board Director Chief Vision & Executive Officer Co-founder, Prxcision & Institute for Clinical Pharmacodynamics
Paul believes the biggest problems in medicine aren’t just technical—they’re moral. As a scientist, he pioneered new ways to optimize the treatment of infectious diseases. As a founder, he’s building systems that restore trust and save lives. His leadership blends clarity of purpose with deep service to others. He doesn’t just talk about changing healthcare. He’s doing it—one decision, one dose, one patient at a time.
Dr. Sujata M. Bhavnani
Board Director Chief Translational Medicine Officer Co-founder, Prxcision & Institute for Clinical Pharmacodynamics
Sujata is more than a scientist—she’s a builder. As co-founder of both ICPD and Prxcision, she has helped shape two organizations grounded in rigor, integrity, and a deep commitment to patient care.
For over 25 years, she has led at the forefront of infectious disease pharmacology — advancing drug development, regulatory policy, and the translation of data into real-world decisions. She brings clarity to complexity and has helped shape how others understand the utility of anti-infective therapies. Her work is precise, strategic, and always anchored in what matters most: better care for patients.
Michael Wyzga
Board Director Former CFO, Genzyme & Lotus Corporation and CEO Radius
Michael has spent his career aligning capital with conscience. At Genzyme and later as CEO of Radius Health, he helped lead organizations that put patients first—and proved that doing good and doing well aren’t mutually exclusive.
He brings sharp financial judgment, strategic experience, and a steady moral compass to the boardroom. He’s here to help build something that lasts. And saves lives.
René brings deep experience at the intersection of science, strategy, and execution. A multi-time CEO and company founder, she has led successful IPOs, formed transformative partnerships, and helped shape the launch of critical anti-infective therapies.
With 25 years in clinical practice and the development and commercialization of infectious disease products, she has built platforms, scaled companies, and played a key role in Cubist’s $9.6B acquisition by Merck.
Her leadership is decisive, visionary, and always driven by purpose.
Anthony Maney, JD
Board Director Strategic Advisor, General Counsel Board Director for Goldstein Group, Kinderhook Bank, Catseye, NextRidge
Anthony brings 30 years of experience guiding high-growth companies through complex legal, regulatory, and financial terrain. A trusted general counsel and seasoned board advisor, he’s led governance reforms, capital strategy, and risk oversight for firms across banking, tech, and private equity.
His counsel is practical, his judgment precise, and his commitment unwavering: to build structures that last—and keep pace with the scale of the vision they serve.
David Buicko
Board Advisor CEO, Galesi Group Chairman, E&B Natural Resources
David is a builder—of cities, industries, and futures. As CEO of the Galesi Group, he helped turn Schenectady from a post-industrial city into a thriving innovation hub—leading large-scale redevelopment projects that sparked economic growth, community renewal, and regional pride.
Today, he also serves as Chairman of E&B Natural Resources and plays a key role on several state-level commissions, including the NYS Regional Economic Development Council and the Canal Redevelopment Commission.
At Prxcision, David brings that same vision and pragmatic insight—not just as an advisor, but as an investor. He supports strategic planning, partnership development, and growth efforts that help us stay focused on what matters most: building something that works and makes a difference.
Mark is a technologist who builds with purpose. With over 30 years of experience architecting enterprise systems, he’s led software development efforts across healthcare, finance, and other regulated industries—transforming complex workflows into elegant, scalable solutions.
Before joining Prxcision, Mark served as CTO at Assuricare and held senior roles at Cambridge Technology Partners and Storyboard Consulting. He has built cloud-native, multi-tenant platforms that integrate seamlessly with systems like Epic and Cerner, enabling speed without compromising security.
Mark brings discipline to design and clarity to complexity. He doesn’t just write code—he builds infrastructure for trust, speed, and scale. His work makes it easier to do the right thing, every time.
Andrew doesn’t just know the science—he knows the people. A seasoned pharmacist and medical affairs leader, he’s spent decades earning the trust of clinicians, researchers, and innovators across the infectious disease community.
He’s the connector—the person who bridges front-line care with cutting-edge solutions. At Prxcision, he ensures our work stays grounded in clinical reality and driven by shared purpose.
Mark builds products that work—in the real world, under real pressure. With decades of experience across robotics, finance, defense, and e-commerce, he’s led engineering and product teams at Amazon Robotics, Goldman Sachs, GE Research, and Valogix.
What sets him apart is his ability to bring order to complexity. Mark translates sprawling needs into elegant systems that scale—always with the user in mind. At Prxcision, he’s helping shape a platform that meets the urgency of modern medicine with the discipline of world-class engineering.
Dr. Robert C. Owens Jr.
Director, Antimicrobial Stewardship Clinical Decision Support Former Co-Director, Antimicrobial Stewardship Program, Maine Medical Center
Rob helped bring the bedside to the blueprint. As co-director of the Antimicrobial Stewardship Program at Maine Medical Center, he spent over a decade guiding clinicians through high-stakes decisions on the front lines of infectious disease care—translating complex science into responsible, real-time action.
A nationally recognized voice in stewardship, Rob has led initiatives in formulary design, audit and feedback, PK-PD optimization, and education. His work shaped not just outcomes, but mindsets—elevating the practice of stewardship to a standard of care.
At Prxcision, he ensures the platform never loses sight of its purpose: supporting the clinician, and protecting the miracle.
Dr. Thomas P. Lodise
Professor of Infectious Diseases Pharmacy, Albany College of Pharmacy & Health Sciences
Tom helped bring the bedside to the blueprint. A globally recognized expert in antibiotic dosing, PK-PD modeling, and antimicrobial stewardship, he’s spent his career shaping how infectious diseases are treated in the real world—one exposure curve, one patient, one insight at a time.
He’s authored more than 240 peer-reviewed papers, led vancomycin dosing reforms through the NIH’s Antibacterial Resistance Leadership Group, and helped define national standards that reduce toxicity and improve outcomes.
But what sets Tom apart is more than data—it’s his clarity, his clinical sensibility, and his unwavering focus on what actually works. At Prxcision, he ensures our algorithms reflect not just the science—but the lived complexity of patient care.
Salman leads marketing, digital design, and social media strategy at Prxcision, where he ensures the story we’re telling is as meaningful as the science behind it. He brings clarity to complexity — translating deep clinical insight into digital experiences that are simple, powerful, and human.
From UI design to public messaging, he shapes how people first encounter our platform and how they remember it.
As the leader of Marketing & Digital Experience, Salman blends technical creativity with deep emotional intelligence. He’s not just designing content. He’s building connection.
.svg)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
